Hexarelin FAQ for Laboratory Researchers
Designed for analytical laboratories and preclinical investigators, this comprehensive Hexarelin FAQ addresses essential chemical properties, laboratory handling procedures, and research protocols. Learn about verified purity standards, optimal reconstitution techniques, storage parameters, and comparative mechanisms within the growth hormone secretagogue receptor class.
Quick answer
Designed for analytical laboratories and preclinical investigators, this comprehensive Hexarelin FAQ addresses essential chemical properties, laboratory handling procedures, and research protocols. Learn about verified purity standards, optimal reconstitution techniques, storage parameters, and comparative mechanisms within the growth hormone secretagogue receptor class.
Key takeaways
- [Hexarelin](/research-peptides/hexarelin) (also known as Examorelin) is a synthetic hexapeptide classified as a potent agonist of the growth hormone secretagogue receptor (GHS-R1a).
- The primary sequence of [Hexarelin](/research-peptides/hexarelin) features a custom-designed amino acid chain containing D-amino acid substitutions (specifically D-2-methyltryptophan and D-phenylalanine) that resist cleavage by ubiquitous circulating endopeptidases.
- Proper reconstitution is critical to maintaining peptide integrity and preventing batch degradation during lab experimentation.
- Lyophilized [Hexarelin](/research-peptides/hexarelin) exhibits robust stability when stored under proper conditions.
Introduction to Hexarelin in Preclinical Research
Hexarelin (also known as Examorelin) is a synthetic hexapeptide classified as a potent agonist of the growth hormone secretagogue receptor (GHS-R1a). Chemically designated as His-D-Mrp-Ala-Trp-D-Phe-Lys-NH2, Hexarelin incorporates non-natural amino acids to enhance metabolic stability against enzymatic degradation compared to endogenous ligands like ghrelin. In preclinical models, this peptide is primarily investigated for its high-affinity receptor binding, signaling cascades in pituitary and cardiac tissue, and downstream somatotropic effects.
As a research compound, Hexarelin serves as a valuable tool in cell culture assays and animal models studying pituitary secretion dynamics, neuroendocrine pathways, and cardiovascular protective mechanisms. Because Hexarelin demonstrates unique metabolic resistance, it allows researchers to isolate specific GHS-R1a pathways without the rapid enzymatic clearance observed with native peptide hormones. All findings documented in academic literature are derived from controlled in vitro assays or in vivo preclinical research protocols.
Molecular Structure and Biochemical Characteristics
The primary sequence of Hexarelin features a custom-designed amino acid chain containing D-amino acid substitutions (specifically D-2-methyltryptophan and D-phenylalanine) that resist cleavage by ubiquitous circulating endopeptidases. Its molecular formula is C47H58N12O6, with a molecular mass of approximately 887.04 g/mol. These chemical modifications stabilize the peptide in aqueous solution, providing consistent bioactivity during extended laboratory assays.
Understanding these structural modifications is essential when designing comparative studies across the growth hormone releasing peptide (GHRP) family. Researchers seeking detailed structural analyses or comparative kinetic data across alternative secretagogues can explore our comprehensive research library for updated technical monographs and assay frameworks.
Reconstitution SOPs for In Vitro and Analytical Protocols
Proper reconstitution is critical to maintaining peptide integrity and preventing batch degradation during lab experimentation. Hexarelin is supplied as a lyophilized (freeze-dried) powder sealed under inert gas. For most cell culture and biochemical protocols, reconstitution with sterile, laboratory-grade Bacteriostatic Water (0.9% benzyl alcohol) or Sterile 0.9% Sodium Chloride for Injection is recommended depending on downstream assay compatibility.
When reconstituting Hexarelin, inject the diluent along the glass vial wall rather than directly onto the lyophilized cake to minimize shear stress. Gently swirl the vial until the powder is fully dissolved; never vortex or vigorously shake peptide solutions, as mechanical agitation can disrupt secondary peptide structures and induce aggregation. For precise analytical protocols, researchers should calculate target molar concentrations based on the lot-specific net peptide content provided on the Certificate of Analysis (COA).
Storage, Stability, and Temperature Control Protocols
Lyophilized Hexarelin exhibits robust stability when stored under proper conditions. Unreconstituted vials should be kept in a desiccated environment at -20°C for long-term storage (up to 24 months) or at 2°C to 8°C for short-term handling (under 90 days). Exposure to light, moisture, and elevated temperatures should be strictly avoided to prevent oxidative cleavage and hydrolysis.
Once reconstituted into aqueous solution, Hexarelin maintains stability at 2°C to 8°C for up to 30 days when prepared with bacteriostatic diluents. If sterile water without preservatives is utilized, reconstituted aliquots should be used immediately or frozen at -80°C to avoid bacterial contamination and degradation. Minimize freeze-thaw cycles by aliquoting reconstituted stock solutions into single-use microcentrifuge tubes prior to deep-freeze storage.
Purity Verification: HPLC, Mass Spectrometry, and COA Standards
In modern preclinical research, assay reproducibility relies heavily on reagent purity and batch-to-batch consistency. PX1 Research subjects every lot of Hexarelin to rigorous analytical evaluation, including High-Performance Liquid Chromatography (HPLC) to verify chemical purity and Electrospray Ionization Mass Spectrometry (ESI-MS) to confirm molecular weight.
Our target threshold for research-grade peptides is a minimum of 98% purity by HPLC area normalization. Each product page features direct access to downloadable, lot-specific Certificates of Analysis issued by an independent ISO 17025 accredited testing facility. Researchers evaluating our manufacturing standards can review our quality assurance protocols to understand our verification methodology.
Endotoxin Testing and Sterility Specifications
Bacterial endotoxins (lipopolysaccharides) introduce significant noise into cell culture models and animal assays by triggering unspecific inflammatory signaling cascades. To ensure reliable experimental outcomes, PX1 Research subjects all peptide lots to quantitative Chromogenic Reagent Limulus Amebocyte Lysate (LAL) testing.
Our strict specifications mandate that endotoxin levels remain below 0.1 EU/mg, well within acceptable parameters for delicate in vitro assays and sensitive animal research models. Maintaining low endotoxin levels ensures that observed biological responses are attributable strictly to GHS-R1a receptor engagement rather than contamination-induced immune activation.
Comparative Analysis: Hexarelin vs. Other Growth Hormone Secretagogues
Hexarelin belongs to a distinct class of synthetic hexapeptides that target the GHS-R1a receptor, but its binding kinetics and potency set it apart from structural relatives. When designing comparative studies, investigators often evaluate Hexarelin alongside GHRP-2, GHRP-6, Ipamorelin, and GHRH analogs such as CJC-1295 No DAC.
While GHRP-6 exhibits significant stimulation of ghrelin-mediated appetite signaling pathways in rodent models, Hexarelin demonstrates higher receptor binding affinity and a stronger acute pulse of growth hormone release in vitro. Conversely, Ipamorelin provides a highly selective binding profile without causing receptor desensitization or elevation of secondary hormones such as cortisol or prolactin. Hexarelin, however, exhibits a unique property among secretagogues: cardioprotective signaling via the CD36 receptor, making it a dual-target research tool in metabolic and cardiovascular preclinical frameworks.
In Vitro and Animal Assay Considerations: Receptor Kinetics
Preclinical investigation reveals that continuous or repetitive exposure to Hexarelin induces rapid desensitization (tachyphylaxis) of the GHS-R1a receptor in both cell cultures and animal models. This down-regulation is characterized by internalizing the G-protein coupled receptor complexes, requiring research protocols to incorporate recovery intervals between experimental treatments.
To maximize signal transduction efficiency during long-term studies, researchers frequently utilize pulse-dosing schedules or combine low-dose GHS-R1a agonists with growth hormone-releasing hormone (GHRH) peptides to investigate synergistic signaling pathways. Explore our detailed guide on secretagogue receptor kinetics for expanded discussion on pulse-frequency optimization in cell models.
Sourcing, Quality Assurance, and Procurement via PX1 Research
Sourcing high-purity research compounds from reliable USA-based suppliers is paramount for academic and private laboratories. PX1 Research synthesizes peptides in state-of-the-art GMP-compliant facilities and verifies purity through accredited ISO 17025 laboratories. Orders ship directly from our fulfillment centers in California and Arizona, offering same-day shipping for orders placed Monday through Friday before 12:00 PM PST.
To support large-scale study designs or institutional procurement, PX1 Research provides custom bulk packaging, consistent lot reservation, and dedicated lab account support. Laboratory managers seeking bulk discounts or high-volume custom synthesis can initiate inquiries through our wholesale portal.
Frequently Asked Questions
What is Hexarelin and what is its primary mechanism of action?
Hexarelin is a synthetic hexapeptide growth hormone secretagogue that acts as a potent selective agonist at the GHS-R1a receptor. Preclinical studies indicate it stimulates the release of growth hormone from anterior pituitary cells and binds to the CD36 receptor in cardiovascular tissues.
How does Hexarelin differ from native ghrelin?
Native ghrelin is an acylated 28-amino acid peptide easily degraded by circulating enzymes. Hexarelin is an 887 Da hexapeptide containing D-amino acid substitutions that significantly increase its metabolic stability and resistance to enzymatic cleavage during laboratory assays.
What solvent should be used to reconstitute Hexarelin for lab research?
Hexarelin readily dissolves in sterile laboratory-grade Bacteriostatic Water (0.9% benzyl alcohol) or Sterile 0.9% Sodium Chloride solution. The choice of solvent depends on the sensitivity of downstream cell culture or analytical assays to preservative agents.
What are the recommended storage temperatures for Hexarelin?
Lyophilized Hexarelin should be stored at -20°C for long-term stability or 2°C to 8°C for short-term use. Once reconstituted, aqueous solution aliquots should be maintained at 2°C to 8°C for up to 30 days or stored at -80°C to prevent degradation across extended timeframes.
What purity level does PX1 Research guarantee for Hexarelin?
PX1 Research guarantees a minimum analytical purity of 98% for Hexarelin as verified by High-Performance Liquid Chromatography (HPLC) and Mass Spectrometry (MS). Every shipment includes lot-specific Certificates of Analysis.
How is endotoxin testing performed on PX1 Research peptides?
Endotoxin levels are quantified using a validated Limulus Amebocyte Lysate (LAL) chromogenic assay. PX1 Research enforces an upper endotoxin limit of <0.1 EU/mg to ensure suitability for sensitive cell assays and animal research.
Does Hexarelin induce receptor desensitization in laboratory assays?
Yes. Preclinical research demonstrates that repeated high-frequency administration of Hexarelin leads to rapid GHS-R1a receptor desensitization (tachyphylaxis). Experimental designs typically incorporate washout periods between treatments to restore receptor sensitivity.
How does Hexarelin compare to Ipamorelin in research models?
Hexarelin exhibits higher peak acute growth hormone release signaling and dual affinity for GHS-R1a and CD36 receptors, but induces faster receptor desensitization. Ipamorelin provides a highly selective GHS-R1a response without affecting cortisol/prolactin pathways or causing rapid desensitization.
Can Hexarelin be co-administered with GHRH analogs in vitro?
In vitro and preclinical animal models frequently combine GHS-R1a agonists like Hexarelin with GHRH analogs like [CJC-1295 No DAC](/product/cjc-1295-no-dac) to study synergistic intracellular cAMP and calcium signaling dynamics.
Where are PX1 Research peptides synthesized and shipped from?
All PX1 Research peptides are synthesized in USA-based, GMP-compliant facilities and dispatched directly from our distribution centers located in California and Arizona.
What documentation is supplied with Hexarelin orders?
Each order includes a lot-specific Certificate of Analysis (COA) detailing HPLC purity graphs, mass spectrometry confirmation, and LAL endotoxin test results from an independent ISO 17025 accredited laboratory.
How can institutional laboratories procure Hexarelin in bulk quantities?
Institutional purchasers and principal investigators can submit bulk requests, reserve dedicated manufacturing lots, or set up recurring research supply accounts through the [PX1 Research wholesale portal](/wholesale).
All products are sold strictly for laboratory and research use only. Not for human or veterinary use, diagnosis, treatment or consumption. Statements have not been evaluated by the FDA.